Lachnospira pectinoschiza
Selected indexed studies
- Gut Microbiota Predicts Treatment Response to Empagliflozin Among MASLD Patients Without Diabetes Mellitus. (Liver Int, 2025) [PMID:39950834]
- Metabolic response of intestinal microbiota to guar gum consumption. (Front Nutr, 2023) [PMID:37457982]
- [Faecal microbiota study reveals specific dysbiosis in spondyloarthritis according to subtype, disease activity and treatment]. (Rev Alerg Mex, 2024) [PMID:38683098]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Gut Microbiota Predicts Treatment Response to Empagliflozin Among MASLD Patients Without Diabetes Mellitus. (2025) pubmed
- Metabolic response of intestinal microbiota to guar gum consumption. (2023) pubmed
- [Faecal microbiota study reveals specific dysbiosis in spondyloarthritis according to subtype, disease activity and treatment]. (2024) pubmed
- The association between flagellin producers in the gut microbiota and HDL-C level in humans. (2023) pubmed
- Fructo-oligosaccharides promote butyrate production over citrus pectin during in vitro fermentation by colonic inoculum from pig. (2024) pubmed
- Characteristics and function of the gut microbiota in patients with rectal neuroendocrine tumors. (2025) pubmed
- Fecal transplantation treatment of antibiotic-induced, noninfectious colitis and long-term microbiota follow-up. (2014) pubmed
- Analysis of 16S rDNA reveals bacterial shift during in vitro fermentation of fermentable carbohydrate using piglet faeces as inoculum. (2003) pubmed
- 16S rDNA analysis of Butyrivibrio fibrisolvens: phylogenetic position and relation to butyrate-producing anaerobic bacteria from the rumen of white-tailed deer. (1996) pubmed
- Associations of the gut microbiome and cardiometabolic risk in adolescence: the HOME study. (2026) pubmed